Association Between Self-Reported Medication Adherence and Therapeutic Inertia in Hypertension: A Secondary Analysis of SPRINT (Systolic Blood Pressure Intervention Trial)

Therapeutic inertia (TI), failure to intensify antihypertensive medication when blood pressure (BP) is above goal, remains prevalent in hypertension management. The degree to which self-reported antihypertensive adherence is associated with TI with intensive BP goals remains unclear. Cross-sectional...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American Heart Association 2024-02, Vol.13 (3), p.e031574-e031574
Main Authors: Jacobs, Joshua A, Derington, Catherine G, Zheutlin, Alexander R, King, Jordan B, Cohen, Jordana B, Bucheit, John, Kronish, Ian M, Addo, Daniel K, Morisky, Donald E, Greene, Tom H, Bress, Adam P
Format: Article
Language:English
Subjects:
adherence
Adult
Aged
Antihypertensive Agents - pharmacology
Antihypertensive Agents - therapeutic use
Blood Pressure
clinical practice pattern
compliance
Cross-Sectional Studies
Female
Humans
hypertension
Hypertension - drug therapy
Hypertension - epidemiology
Male
Medication Adherence
Original Research
Self Report
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Therapeutic inertia (TI), failure to intensify antihypertensive medication when blood pressure (BP) is above goal, remains prevalent in hypertension management. The degree to which self-reported antihypertensive adherence is associated with TI with intensive BP goals remains unclear. Cross-sectional analysis was performed of the 12-month visit of participants in the intensive arm of SPRINT (Systolic Blood Pressure Intervention Trial), which randomized adults to intensive (
ISSN:2047-9980
2047-9980
DOI:10.1161/JAHA.123.031574